ArticleNews reportPHN-05332026-11-01 22:57 CT
Dzulkefly: No special Budget 2027 allocation for Ozempic, Mounjaro treatments
Source · The Malaysian Reserve
TLDR
Malaysia’s Health Minister Dzulkefly Ahmad said no dedicated funding was allocated for Ozempic and Mounjaro treatments under Budget 2026, according to the excerpt. He reported that 240 treatment applications were approved between January and September, costing RM2.56 million through existing Health Ministry funding.
01—Key points
- 01Approved treatments were funded through the ministry’s Special Approval Medicines mechanism.
- 02The ministry’s multidisciplinary obesity programme operates at 33 government clinics, supported by specialists from 13 ministry hospitals.
- 03The supplied title refers to Budget 2027, while the excerpt’s headline and body refer to Budget 2026.
Why it matters Editorial
The report describes how Malaysia funds access to GLP-1 treatments without a dedicated budget allocation.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.